Adam Grossman is President, Chief Executive Officer and Director of Adma Biologics, Inc. (ADMA). The company reported total compensation of $10,237,326 for fiscal year 2025.
| Salary | $925,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $4,049,994 |
| Option awards | $4,049,998 |
| Non-equity incentive plan | $1,156,250 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $56,084 |
| Total | $10,237,326 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Adma Biologics, Inc. filed April 15, 2026, accession 0001140361-26-014799.
| Peer-group chief executive median | $9,300,485 |
|---|---|
| Difference from that median | $936,841 |
| Percentile within the disclosed peer group | 57th |
| Peers with a disclosed figure | 20 |
Medians and percentiles are computed across the peer group Adma Biologics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Adam Grossman this page | President, Chief Executive Officer and Director | $10,237,326 |
| Kaitlin Kestenberg | Chief Operating Officer & Senior Vice President, Compliance | $3,488,647 |
| Brad Tade | Former Executive Vice President and Chief Financial Officer | $2,823,630 |
| Paul Kohler | Current Chief Financial Officer and Treasurer | $2,296,949 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Adma Biologics, Inc. compensation brief.
Adam Grossman's compensation sits inside Adma Biologics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.